ZBH — Zimmer Biomet Holdings, Inc.
$98.56-0.25%
Last close: · regular session
Last 60 sessions
ZBH closed at $98.56 (-0.25%) on Oct 23, 2026. Float: 195.4M shares. Latest SEC filing: SCHEDULE 13G/A on Aug 13, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for ZBH in the TickerWise workspace.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NYSE
- Employees: 17,000
- Website: https://www.zimmerbiomet.com
Latest SEC filings for ZBH
Latest ZBH news
- Zimmer Biomet and Think Surgical Extend Exclusive Distribution Agreement Read article
- Should Value Investors Buy Zimmer Biomet (ZBH) Stock? Read article
- Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy? Read article
- Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.